Viatris Inc: 23 recalls on record

Recalls filed with 1 agency: FDA (23).

First recall on record: May 11, 2022. Most recent: April 15, 2026.

Risk classification: Class I: 1 · Class II: 21 · Class III: 1

Most recent recalls

DateAgencyProduct
April 15, 2026FDAXanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distri…D-0444-2026
January 22, 2025FDACardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distribu…D-0204-2025
January 22, 2025FDACardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distribut…D-0203-2025
December 18, 2024FDALevothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-1817…D-0121-2025
December 18, 2024FDALevothyroxine Sodium Tablets USP, 125 mcg, packaged in a) 90-count bottles (NDC 0378-1813…D-0118-2025
December 18, 2024FDALevothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815…D-0120-2025
December 18, 2024FDALevothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0378-1805-…D-0125-2025
December 18, 2024FDALevothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC 0378-1823…D-0119-2025
December 18, 2024FDALevothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0378-1803-…D-0124-2025
December 18, 2024FDALevothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC 0378-1819…D-0122-2025
December 18, 2024FDALevothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC 0378-1811…D-0128-2025
December 18, 2024FDALevothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0378-1807-…D-0126-2025
December 18, 2024FDALevothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0378-1800-…D-0123-2025
December 18, 2024FDALevothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809…D-0127-2025
July 24, 2024FDACardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in S…D-0602-2024
July 24, 2024FDACardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Si…D-0603-2024
May 8, 2024FDAValacyclovir Tablets USP, 500 mg, 90 count bottles, Rx Only, Manufactured for: Mylan Phar…D-0481-2024
June 14, 2023FDALevsin injection (hyoscyamine sulfate injection, USP), 0.5 mg per ml in water for Injecti…D-0866-2023
November 23, 2022FDACarvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals In…D-0063-2023
November 16, 2022FDAOctreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For …D-0058-2023
October 5, 2022FDAAmpicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials …D-1542-2022
May 18, 2022FDAXanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only, Distribut…D-0854-2022
May 11, 2022FDAalprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: G…D-0844-2022

Questions about this company

How many recalls does Viatris Inc have?
Recalert has 23 U.S. recalls on record for Viatris Inc, published between May 11, 2022 and April 15, 2026.
What was the most recent Viatris Inc recall?
FDA recall D-0444-2026, published April 15, 2026: Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91
Which agencies have handled Viatris Inc recalls?
Viatris Inc appears as the recalling firm in recalls from: FDA (23).

Do you carry products from Viatris Inc? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related companies